Plainwell, MI, United States of America

Philip F Vonvoigtlander

This inventor holds 1 USPTO granted patent. Top assignee: The Upjohn Co.. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip F Vonvoigtlander. Retrieved from https://idiyas.com/inventor/philip-f-vonvoigtlander

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Philip F Vonvoigtlander

Introduction

Philip F Vonvoigtlander is a notable inventor based in Plainwell, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-convulsant drugs. His work has implications for the treatment of central nervous system disorders.

Latest Patents

Vonvoigtlander holds a patent for "Cis-N-(2-aminocycloaliphatic)benzamide anti-convulsants." This patent describes certain cis-N-(2-amino-cycloaliphatic)benzamides that exhibit CNS seizure-blocking properties. The formula includes variations where m is 0, n is 2, and r is alkyl, with R1 and R2 forming a pyrrolidine ring. The compounds have been found to possess anti-convulsant drug properties with minimal analgesic effects.

Career Highlights

Throughout his career, Vonvoigtlander has been associated with The Upjohn Company, a prominent player in the pharmaceutical industry. His work has contributed to advancements in drug development, particularly in the area of seizure management.

Collaborations

One of his notable collaborators is Jacob Szmuszkovicz. Together, they have worked on various projects that enhance the understanding and treatment of neurological conditions.

Conclusion

Philip F Vonvoigtlander is a distinguished inventor whose work in anti-convulsant drug development has made a significant impact in the pharmaceutical field. His contributions continue to influence the treatment of central nervous system disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…